Jingwan Zhou

573 total citations · 2 hit papers
7 papers, 307 citations indexed

About

Jingwan Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jingwan Zhou has authored 7 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Jingwan Zhou's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Ferroptosis and cancer prognosis (3 papers). Jingwan Zhou is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Ferroptosis and cancer prognosis (3 papers). Jingwan Zhou collaborates with scholars based in China, Hong Kong and United States. Jingwan Zhou's co-authors include Bing Yao, Zhou Yang, Wei Su, Jun Xiang, Qing Guan, Xiyi Wei, Shuang Qu, Yunjun Wang, Chao Qin and Dan Zhao and has published in prestigious journals such as Oncogene, Molecular Cancer and Cell Reports.

In The Last Decade

Jingwan Zhou

7 papers receiving 305 citations

Hit Papers

HIF-1α drives resistance to ferroptosis in solid tumors b... 2023 2026 2024 2025 2023 2025 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingwan Zhou China 6 225 181 111 31 26 7 307
Anqi Dong China 5 173 0.8× 127 0.7× 154 1.4× 32 1.0× 18 0.7× 8 245
Weizi Hu China 8 282 1.3× 233 1.3× 48 0.4× 50 1.6× 28 1.1× 8 346
Wailong Zou China 4 235 1.0× 162 0.9× 221 2.0× 62 2.0× 23 0.9× 7 339
Jiantao Mo China 6 192 0.9× 156 0.9× 94 0.8× 40 1.3× 26 1.0× 14 283
Xiaonan Sheng China 10 201 0.9× 193 1.1× 137 1.2× 51 1.6× 38 1.5× 22 332
Yunyun Li China 9 210 0.9× 194 1.1× 84 0.8× 34 1.1× 23 0.9× 17 305
Yuhei Komiyama Japan 2 219 1.0× 186 1.0× 230 2.1× 52 1.7× 17 0.7× 2 334
Shengren Cen China 6 202 0.9× 160 0.9× 119 1.1× 43 1.4× 26 1.0× 8 284

Countries citing papers authored by Jingwan Zhou

Since Specialization
Citations

This map shows the geographic impact of Jingwan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwan Zhou more than expected).

Fields of papers citing papers by Jingwan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwan Zhou. The network helps show where Jingwan Zhou may publish in the future.

Co-authorship network of co-authors of Jingwan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwan Zhou. A scholar is included among the top collaborators of Jingwan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwan Zhou. Jingwan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Qu, Shuang, Yang Zhou, Ji Yi, et al.. (2025). PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer. Oncogene. 44(32). 2814–2830. 4 indexed citations
2.
Yang, Zhou, Wei Su, Qinglin Zhang, et al.. (2025). Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer. Advanced Science. 12(12). e2408845–e2408845. 25 indexed citations breakdown →
3.
Yao, Bing, Shang Li, Jingwan Zhou, et al.. (2023). EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN. Advanced Science. 11(2). e2302037–e2302037. 8 indexed citations
4.
Zhou, Yang, Chengjian Ji, Xiaohan Ren, et al.. (2023). OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis. iScience. 26(11). 108148–108148. 12 indexed citations
5.
Yang, Zhou, Wei Su, Xiyi Wei, et al.. (2023). HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Reports. 42(8). 112945–112945. 127 indexed citations breakdown →
6.
Yao, Bing, Sha Zhu, Mingkun Chen, et al.. (2022). The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Molecular Cancer. 21(1). 119–119. 33 indexed citations
7.
Yao, Bing, Qinglin Zhang, Zhou Yang, et al.. (2022). CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA. Molecular Cancer. 21(1). 140–140. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026